Hillevax

Hillevax Stock-Based Compensation

Delisted

The Stock-Based Compensation (SBC) of Hillevax (HLVX) as of Nov 20, 2026 is 20.78 M USD. In the previous year, Stock-Based Compensation (SBC) was 13.59 M USD — a change of 52.94% (higher).

Stock-Based Compensation

20.78 MUSD

YoY

52.94%

Last updated:

Stock-Based Compensation (SBC) of Hillevax is 2024 20.78 M USD. Stock-Based Compensation (SBC) of Hillevax was 2023 13.59 M USD. It decreases by 52.94% higher compared to the previous year.

The Hillevax Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2020
0.00 USD
Jan 1, 2021
67,000.00 USD
Jan 1, 2022
3.00 M USD
Jan 1, 2023
13.59 M USD
Jan 1, 2024
20.78 M USD
The Hillevax Stock-Based Compensation history
YEARStock-Based CompensationYoY
20.78 MUSD+52.94%
13.59 MUSD+352.55%
3.00 MUSD+4,382.09%
67,000.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hillevax Stock analysis

What does Hillevax do? HilleVax, Inc. develops and commercializes novel vaccines, focusing on HIL-214, a bivalent virus-like particle (VLP) vaccine candidate for norovirus-induced acute gastroenteritis. The vaccine combines VLPs for norovirus genotypes GI.1 and GII.4 with an aluminum hydroxide adjuvant to enhance immune response. HIL-214 targets moderate-to-severe cases of norovirus infection, which causes symptoms like diarrhea, vomiting, and dehydration. The company's primary revenue stream will come from the future commercialization of HIL-214 after regulatory approval, with potential sales to healthcare providers and public health programs. Hillevax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hillevax stock

Stock-Based Compensation (SBC) of Hillevax is 20.78 M USD in 2024.

Stock-Based Compensation (SBC) of Hillevax changed from 13.59 M USD to 20.78 M USD, representing a 52.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Hillevax since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Hillevax historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Hillevax

All Key Metrics — Hillevax